Investigation conclusion: it is indicated that the product is not returning for evaluation.Therefore, a review of the entire testing history for the reported lot was performed.In-house testing on strip lot 370105ar meets release criteria.The product performed as expected.A review of the manufacturing records for the lot did not uncover any relevant non-conformances.The lot meets release specification.It was reported that the patient has a severe bladder infection.Certain medical conditions including severe infections may impact the performance of the assay.Although a potential patient sample interference was identified, a root cause could not be determined from the information provided by the customer.Capa-(b)(4) was initiated to investigate the cause of highly discrepant results.Further investigation into this issue is being performed under capa-(b)(4).
|